Svati Shah, MD, MHS, Named the Director of Duke Kannapolis Research
CTSI announces that Svati Shah, MD, MHS, has been named the Director of Duke Kannapolis Research. In this role, she will direct all activities and projects based at the Duke CTSI clinical research facility in Kannapolis.
MeTree software recommended by President’s Cancer Panel
The President's Cancer Panel has recommended MeTree, as a tool to facilitate clinical decision-making, which asks patients to enter information such as diet, exercise, smoking, and family history.
How you can help scientists better understand COVID variants through wearable devices
Duke researchers are investigating whether data from your smartphone and smartwatch can help determine if you have COVID-19 and how severe the infection could get.
How a Rare Brain Mutation Spread Across America
The Bowlin family knew they had a history of malformations in the brain. But they had no idea how far back it went.
Donald receives $3M Established Investigator MIRA award
Bruce Donald, PhD, has received a five year, $2.9 million Established Investigator Maximizing Investigators’ Research Award (MIRA)
Pilot funding launches new wave of COVID research
The Duke University School of Medicine Precision Genomics Collaboratory awarded $15,000 pilot grants to young investigators in January 2021. These grants focused on COVID-19 research that broadly involved genetics and genomics. One year later, these young investigators are in the thick of cutting-edge research.
Your gut senses the difference between real sugar and artificial sweetener
Sugar preference isn’t just a matter of taste - it’s deeper than that
PGC Announces Student Pilot Grant Awardees
The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 10 pilot grants of $2,000 each to SOM Biomedical PhD students.
Tune Therapeutics: New Startup Co-founded by Gersbach Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases
Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will.
Watch: Lori Orlando's interview with WRAL on family health history
Lori Orlando, MD, MHS, MMCI, recently spoke with WRAL on the importance of talking with loved ones about family health history.